Patent & Trade Mark
Attorneys
 
English
FB Rice are
Your Global Intellectual Property Partner
We are
Experts in Navigating IP in the Asia Pacific Region
Working with clients in
AU & NZ
South East Asia
International
Thanks to many years of global experience, FB Rice has a network of trusted advisors in all key jurisdictions. We turn to those advisors when assisting our clients to promote their interests.

For specific information on our Asia Pacific capability, click here.
One door to South East Asia
For a seamless service for filing and prosecuting patent and trade mark applications in South East Asia, click here.
Joanne Martin

Partner

Joanne Martin
"Businesses which spend time and money on creating, developing and promoting their brands recognise that trade marks are valuable commercial assets, and registration of their marks is an essential part of their IP strategy."
"Businesses which spend time and money on creating, developing and promoting their brands recognise that trade marks are valuable commercial assets, and registration of their marks is an essential part of their IP strategy."
New Zealand to introduce a one-year grace period
New Zealand to introduce a one-year grace period
New Zealand looks set to introduce a new one-year grace period into the Patents Act 2013 after ratifying the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) on 25 October 2018.
New Zealand looks set to introduce a new one-year grace period into the Patents Act 2013 after ratifying the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) on 25 October 2018.
07 May 2018
New Zealand relaxes support required for amending patent specifications
New Zealand relaxes support required for amending patent specifications
Based on a recent decision by New Zealand’s Intellectual Property Office (IPONZ), patent applicants wishing to amend the specification during examination in New Zealand no longer need to provide a specific statement of support in the original specification for each and every proposed amendment.
Read more
Based on a recent decision by New Zealand’s Intellectual Property Office (IPONZ), patent applicants wishing to amend the specification during examination in New Zealand no longer need to provide a specific statement of support in the original specification for each and every proposed amendment.
Greg Potter

Patent Attorney

Greg Potter
Greg’s technical skills and knowledge span across the electrical and computer systems engineering and physics disciplines, with an extensive background including R&D in the fields of semiconductor physics, plasma physics and medical imaging. Coupled with this, Greg has experience in scientific modelling, algorithm design, laboratory procedures, field measurements and teaching.
Greg’s technical skills and knowledge span across the electrical and computer systems engineering and physics disciplines, with an extensive background including R&D in the fields of semiconductor physics, plasma physics and medical imaging. Coupled with this, Greg has experience in scientific modelling, algorithm design, laboratory procedures, field measurements and teaching.
11 January 2019
A year in review - IP and FB Rice during 2018
A year in review - IP and FB Rice during 2018
As we have entered the new year, it is an opportunity to reflect on 2018. It certainly has been a busy year and the Australian IP landscape has shifted, impacting our clients on a number of fronts.
Read more
As we have entered the new year, it is an opportunity to reflect on 2018. It certainly has been a busy year and the Australian IP landscape has shifted, impacting our clients on a number of fronts.
Interfering RNA (iRNA) is no interference to manner of manufacture in Australia
Interfering RNA (iRNA) is no interference to manner of manufacture in Australia
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.
PRIVACY
DISCLAIMER
CONTACT US
SITE MAP
Sydney
Melbourne
Perth
Brisbane
Adelaide
Parramatta
FOLLOW US
COPYRIGHT 2010 - 2019 FB RICE, ALL RIGHTS RESERVED | PATENT AND TRADE MARK ATTORNEYS